Bristol -Myers Squibb News

Bristol -Myers Squibb News

BenchmarkJournal.com Free Analyst Review for BMY, ACF, FRE, TD, SWY and CBB

BenchmarkJournal.com Free Analyst Review for BMY, ACF, FRE, TD, SWY and CBB

SYS-CON Media - 23 minutes ago
LONDON -- (Marketwire) -- 11/06/09 -- Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear ...

Repligen Reports Second Quarter Fiscal Year 2010 Financial Results

Repligen Reports Second Quarter Fiscal Year 2010 Financial Results

Reuters - 2 hours ago
WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for ...

Repligen Reports Second Quarter Fiscal Year 2010 Financial Results

Repligen Reports Second Quarter Fiscal Year 2010 Financial Results

PharmaLive.com - 15 minutes ago
WALTHAM, MA – November 5, 2009 – Repligen Corporation (NASDAQ: RGEN) today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was ...

A Cure for Cancer?

A Cure for Cancer?

CNBC - Nov 3, 2009
Bristol-Myers Squibb and Pfizer are “the most conservative ways to play the war against cancer,” Cramer said Monday. Both companies own strong drug pipelines, the stocks are cheap, and the share ...

Zyngenia, Inc. Raises $10 Million in Series A Funding

Zyngenia, Inc. Raises $10 Million in Series A Funding

Reuters - 1 hour ago
- Next-Generation Biotherapeutics Company Appoints Board of Directors, Management Team - ROCKVILLE, Md., Nov. 4 /PRNewswire/ -- Zyngenia, Inc., a privately held biotherapeutics company focused on ...

Syndicate content